Efficacy of Brolucizumab in Polyp Regression of Treatment-Naive Polypoidal Choroidal Vasculopathy and Its Effect on 1-Year Treatment Outcome

• DOI: 10.3341/kjo.2023.0145
• Publication Date: 2024-04-08T06:30:07Z
• Authors: Seung Hun Lee; Hyo Song Park; Jung Woo Han
• Keywords: Male; Time Factors; Choroid; Fundus Oculi; Visual Acuity; Angiogenesis Inhibitors; Choroid Diseases; Middle Aged; Antibodies, Monoclonal, Humanized; Choroidal Neovascularization; 03 medical and health sciences; Polyps; Treatment Outcome; 0302 clinical medicine; Intravitreal Injections; Humans; Original Article; Female; Fluorescein Angiography; Tomography, Optical Coherence; Retrospective Studies; Aged; Follow-Up Studies

To evaluate the efficacy of intravitreal brolucizumab in polyp regression treatment-naive polypoidal choroidal vasculopathy (PCV) patients and its effect on 1-year treatment outcome.